Literature DB >> 17260344

Transcranial imaging of substantia nigra hyperechogenicity in a Taiwanese cohort of Parkinson's disease.

Yu-Wen Huang1, Jiann-Shing Jeng, Chung-Fen Tsai, Li-Ling Chen, Ruey-Meei Wu.   

Abstract

Transcranial Doppler imaging (TCDI) has been used as a noninvasive diagnostic tool to differentiate Parkinson's disease (PD) from atypical parkinsonism by detecting hyperechogenicity in the substantia nigra (SN). To our knowledge, no TCDI data are available for Asian populations, and TCDI sensitivity is uncertain across populations. Early-onset PD (EOPD) represents a specific PD subtype based on clinical features and pathogenic mechanisms. It is not known if EOPD patients have abnormal echogenicity in SN comparable to late-onset PD (LOPD) patients. We assessed the area of SN hyperechogenicity (hyper-SN) and a ratio of hyper-SN over ipsilateral midbrain (S/M ratio) with TCDI in 164 healthy Taiwanese, 40 EOPD patients, and 40 LOPD patients. The upper 95th percentile values for hyper-SN and S/M ratio were 0.20 cm(2) and 0.07. Our results indicate that S/M ratio is a more sensitive measure than hyper-SN in diagnosing PD. Approximately 92.5% of the LOPD patients and 57.5% of the EOPD patients had S/M ratios >/= 0.07. Enlarged hyperechogenicity of SN is a common finding in LOPD, but not in EOPD. Iron-independent mechanisms of SN cell degeneration in EOPD distinct from that in LOPD might contribute to the sonographic findings. (c) 2006 Movement Disorder Society.

Entities:  

Mesh:

Year:  2007        PMID: 17260344     DOI: 10.1002/mds.21372

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  17 in total

1.  Transcranial sonography on Parkinson's disease and essential tremor in a Chinese population.

Authors:  Wei-Feng Luo; Ying-Chun Zhang; Yu-Jing Sheng; Jun-Chu Fang; Chun-Feng Liu
Journal:  Neurol Sci       Date:  2011-12-11       Impact factor: 3.307

Review 2.  Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: no.

Authors:  Uwe Walter
Journal:  J Neural Transm (Vienna)       Date:  2010-12-29       Impact factor: 3.575

3.  Basal ganglia hyperechogenicity does not distinguish between patients with primary dystonia and healthy individuals.

Authors:  Johann Hagenah; Inke R König; Charlotte Kötter; Günter Seidel; Christine Klein; Norbert Brüggemann
Journal:  J Neurol       Date:  2010-11-02       Impact factor: 4.849

Review 4.  Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: yes.

Authors:  Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2011-01-05       Impact factor: 3.575

Review 5.  Hyperechogenicity of the substantia nigra: pitfalls in assessment and specificity for Parkinson's disease.

Authors:  Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2010-09-10       Impact factor: 3.575

6.  The measuring of substantia nigra hyperechogenicity in an Italian cohort of Parkinson disease patients: a case/control study (NOBIS Study).

Authors:  Patrizio Prati; A Bignamini; L Coppo; A Naldi; C Comi; R Cantello; G Gusmaroli; U Walter
Journal:  J Neural Transm (Vienna)       Date:  2017-04-27       Impact factor: 3.575

Review 7.  Transcranial duplex in the differential diagnosis of parkinsonian syndromes: a systematic review.

Authors:  Annemarie M M Vlaar; Angela Bouwmans; Werner H Mess; Selma C Tromp; Wim E J Weber
Journal:  J Neurol       Date:  2009-02-17       Impact factor: 4.849

8.  Illicit stimulant use is associated with abnormal substantia nigra morphology in humans.

Authors:  Gabrielle Todd; Carolyn Noyes; Stanley C Flavel; Chris B Della Vedova; Peter Spyropoulos; Barry Chatterton; Daniela Berg; Jason M White
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

9.  Specificity of transcranial sonography in parkinson spectrum disorders in comparison to degenerative cognitive syndromes.

Authors:  Kristina Laučkaitė; Daiva Rastenytė; Danguolė Šurkienė; Antanas Vaitkus; Andrius Sakalauskas; Arūnas Lukoševičius; Rymantė Gleiznienė
Journal:  BMC Neurol       Date:  2012-03-08       Impact factor: 2.474

10.  Specificity and sensitivity of transcranial sonography of the substantia nigra in the diagnosis of Parkinson's disease: prospective cohort study in 196 patients.

Authors:  Angela E P Bouwmans; Annemarie M M Vlaar; Werner H Mess; Alfons Kessels; Wim E J Weber
Journal:  BMJ Open       Date:  2013-04-02       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.